Evidence map›Paper›PMID 33883036›Full record

ArticleTropical medicine and health2021

Phenotypic and haplotypic profiles of insecticide resistance in populations of Aedes aegypti larvae (Diptera: Culicidae) from central Lao PDR.

Takaki Shimono, Seiji Kanda, Pheophet Lamaningao, Yuki Murakami, Andrew Waleluma Darcy, Nobuyuki Mishima, Somchit Inthavongsack, Odai Soprasert, Thonelakhanh Xaypangna, Toshimasa Nishiyama

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Takaki ShimonoDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Seiji KandaDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan. kandas@hirakata.kmu.ac.jp.ORCID http://orcid.org/0000-0002-1797-3509
Pheophet LamaningaoDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Yuki MurakamiDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Andrew Waleluma DarcyDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Nobuyuki MishimaDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Somchit InthavongsackStation of Malariology, Parasitology, and Entomology, Khammouane Provincial Health Department, Thakhek, Khammouane Province, Lao PDR.
Odai SoprasertKhammouane Provincial Health Department, Thakhek, Khammouane Province, Lao PDR.
Thonelakhanh XaypangnaKhammouane Provincial Health Department, Thakhek, Khammouane Province, Lao PDR.
Toshimasa NishiyamaDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Kansai Medical University · JPPublic Health Department · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAedes aegypti, which is widely distributed in the Lao People's Democratic Republic (PDR), is the primary vector of arboviral diseases. Chemical insecticides have been intensively used to eliminate mosquito-borne diseases, resulting in the development of insecticide resistance. However, little is known about the insecticide resistance of mosquito populations in Lao PDR and the mechanisms responsible for it, which have important implications for vector management programs. Here, we examined the phenotypic and haplotypic profiles of insecticide resistance in populations of Ae. aegypti larvae from central Lao PDR.

methodsAe. aegypti larvae were collected from four sites in Lao PDR, and their susceptibility to temephos, deltamethrin, permethrin, and Bacillus thuringiensis israelensis (Bti) was tested using larval bioassays. Synergistic tests were also conducted to evaluate the activity of insecticide-metabolizing enzymes in the larvae. Deltamethrin-resistant and Deltamethrin-susceptible larvae were then genotyped for knockdown resistance (kdr) mutations to determine the associations between each genotype and resistance.

resultsAe. aegypti larvae from central Lao PDR were considered to be "resistant" (<98% mortality) to organophosphates and pyrethroids. The bio-insecticide Bti remains effective against such larvae. The resistance mechanisms of Ae. aegypti larvae were found to vary among populations, especially for pyrethroid resistance. Kdr mutations were significantly associated with deltamethrin resistance in Ae. aegypti from the Xaythany population. In contrast, synergist assays with piperonyl butoxide suggested that cytochrome P450 monooxygenases played an important role in the resistance seen in the Khounkham and Thakhek populations.

conclusionThis study obtained information that will aid the design and implementation of insecticide-based vector management of Ae. aegypti in central Lao PDR. Ae. aegypti larvae from central Lao PDR were highly susceptible to Bti, while they were resistant to temephos at a diagnostic dose of 0.0286 mg/L. Given the limited number of insecticides that are approved for vector control, it is important to alternate between temephos and other larvicides, such as Bti and pyriproxyfen. The differences in pyrethroid resistance mechanisms seen among the Ae. aegypti populations highlight the need to tailor vector-control strategies to each region to increase the success of dengue control in Lao PDR.

Indexed as

Aedes aegyptiBioassayDengueInsecticide resistancekdr mutationLao PDRP450sSynergist

Identifiers

PMID33883036
PMCPMC8061177
OpenAlexW3152519474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.